Public-registry site landscape for NCT07678827, a Attention Deficit Hyperactivity Disorder study sponsored by Alvogen Korea. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07678827 (registry record) |
| Sponsor | Alvogen Korea |
| Condition(s) | Attention Deficit Hyperactivity Disorder; Attention-Deficit / Hyperactivity Disorder; ADHD |
| Phase | PHASE3 |
| Listed sites | 1 |
| Site countries | South Korea |
Eichor generates a preliminary site-risk snapshot for NCT07678827 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →